Innovating Works

EBG MedAustron

Desconocido
PRISMAP: The European medical isotope programme Production of high purity isotopes by mass separation EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un H2020: H2020-INFRAIA-2018-2020 PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation proposes to federate a consortium of...
2021-07-07 - 2025-04-30 | Financiado
HITRIplus: Heavy Ion Therapy Research Integration plus EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un H2020: H2020-INFRAIA-2018-2020 The goal of Heavy Ion Therapy Research Integration plus (HITRIplus) is to integrate and propel biophysics and medical research on cancer tre...
2021-03-08 - 2025-09-30 | Financiado
ENSAR2: European Nuclear Science and Application Research 2 EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un H2020: H2020-INFRAIA-2014-2015 ENSAR2 is the integrating activity for European nuclear scientists who are performing research in three of the major subfields defined by Nu...
2016-02-26 - 2021-08-31 | Financiado
OMA: Optimization of Medical Accelerators EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un H2020: H2020-MSCA-ITN-2015 Cancer is a major social problem, and it is the main cause of death between the ages 45-65 years. In the treatment of cancer, radio therapy...
2015-07-28 - 2020-01-31 | Financiado
MEDICIS-PROMED: MEDICIS produced radioisotope beams for medicine EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un H2020: H2020-MSCA-ITN-2014 Pure accelerated radioisotope beams have been used for 50 years in fundamental physics R&D, e.g. for nuclear structure studies (pear shaped...
2014-12-12 - 2019-03-31 | Financiado
ULICE: Union of Light Ion Centres in Europe EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un FP7: ULICE is a 4-year project set up by 20 leading European research organisations, including 2 leading European industrial partners (Siemens an...
Financiado
PARTNER: Particle Training Network for European Radiotherapy EBG Entwicklungs und Betriebsgesellschaft MedAustron GmbH participó en un FP7: A Particle Training Network for European Radiotherapy (PARTNER) will be established in response to the critical need for reinforcing researc...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.